BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 30209132)

  • 1. The TEA domain family transcription factor TEAD4 represses murine adipogenesis by recruiting the cofactors VGLL4 and CtBP2 into a transcriptional complex.
    Zhang W; Xu J; Li J; Guo T; Jiang D; Feng X; Ma X; He L; Wu W; Yin M; Ge L; Wang Z; Ho MS; Zhao Y; Fei Z; Zhang L
    J Biol Chem; 2018 Nov; 293(44):17119-17134. PubMed ID: 30209132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. OTUD6A orchestrates complex modulation of TEAD4-mediated transcriptional programs.
    Kim HJ; Choi Y; Lee Y; Hwangbo M; Kim J
    FEBS Lett; 2024 May; 598(9):1045-1060. PubMed ID: 38594215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Computational insights into the interaction mechanism of transcription cofactor vestigial-like protein 4 binding to TEA domain transcription factor 4 by molecular dynamics simulation and molecular mechanics generalized Born/surface area) calculation.
    Gao J; Zhang Y; Chen H; Chen Q; Feng D; Zhang L; Li C
    J Biomol Struct Dyn; 2019 Jul; 37(10):2538-2545. PubMed ID: 30051771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. VGLL4 targets a TCF4-TEAD4 complex to coregulate Wnt and Hippo signalling in colorectal cancer.
    Jiao S; Li C; Hao Q; Miao H; Zhang L; Li L; Zhou Z
    Nat Commun; 2017 Jan; 8():14058. PubMed ID: 28051067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Wnt3a disrupts GR-TEAD4-PPARγ2 positive circuits and cytoskeletal rearrangement in a β-catenin-dependent manner during early adipogenesis.
    Park B; Chang S; Lee GJ; Kang B; Kim JK; Park H
    Cell Death Dis; 2019 Jan; 10(1):16. PubMed ID: 30622240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. VGLL4 with low YAP expression is associated with favorable prognosis in colorectal cancer.
    Kim JY; Kim EK; Lee WM; Hong YO; Lee H
    APMIS; 2020 Oct; 128(10):543-551. PubMed ID: 32794608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of the acylation of TEAD4 on its interaction with co-activators YAP and TAZ.
    Mesrouze Y; Meyerhofer M; Bokhovchuk F; Fontana P; Zimmermann C; Martin T; Delaunay C; Izaac A; Kallen J; Schmelzle T; Erdmann D; Chène P
    Protein Sci; 2017 Dec; 26(12):2399-2409. PubMed ID: 28960584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA-binding mechanism of the Hippo pathway transcription factor TEAD4.
    Shi Z; He F; Chen M; Hua L; Wang W; Jiao S; Zhou Z
    Oncogene; 2017 Jul; 36(30):4362-4369. PubMed ID: 28368398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural basis of YAP recognition by TEAD4 in the hippo pathway.
    Chen L; Chan SW; Zhang X; Walsh M; Lim CJ; Hong W; Song H
    Genes Dev; 2010 Feb; 24(3):290-300. PubMed ID: 20123908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ligand-dependent corepressor (LCoR) represses the transcription factor C/EBPβ during early adipocyte differentiation.
    Cao H; Zhang S; Shan S; Sun C; Li Y; Wang H; Yu S; Liu Y; Guo F; Zhai Q; Wang YC; Jiang J; Wang H; Yan J; Liu W; Ying H
    J Biol Chem; 2017 Nov; 292(46):18973-18987. PubMed ID: 28972158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased TEAD4 expression and nuclear localization in colorectal cancer promote epithelial-mesenchymal transition and metastasis in a YAP-independent manner.
    Liu Y; Wang G; Yang Y; Mei Z; Liang Z; Cui A; Wu T; Liu CY; Cui L
    Oncogene; 2016 May; 35(21):2789-800. PubMed ID: 26387538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HOXB13 suppresses proliferation, migration and invasion, and promotes apoptosis of gastric cancer cells through transcriptional activation of VGLL4 to inhibit the involvement of TEAD4 in the Hippo signaling pathway.
    Geng H; Liu G; Hu J; Li J; Wang D; Zou S; Xu X
    Mol Med Rep; 2021 Oct; 24(4):. PubMed ID: 34396425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Grape skin extract reduces adipogenesis- and lipogenesis-related gene expression in 3T3-L1 adipocytes through the peroxisome proliferator-activated receptor-γ signaling pathway.
    Jeong YS; Hong JH; Cho KH; Jung HK
    Nutr Res; 2012 Jul; 32(7):514-21. PubMed ID: 22901559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrative genomics analysis reveals the multilevel dysregulation and oncogenic characteristics of TEAD4 in gastric cancer.
    Lim B; Park JL; Kim HJ; Park YK; Kim JH; Sohn HA; Noh SM; Song KS; Kim WH; Kim YS; Kim SY
    Carcinogenesis; 2014 May; 35(5):1020-7. PubMed ID: 24325916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biochemical properties of VGLL4 from Homo sapiens and Tgi from Drosophila melanogaster and possible biological implications.
    Mesrouze Y; Meyerhofer M; Zimmermann C; Fontana P; Erdmann D; Chène P
    Protein Sci; 2021 Sep; 30(9):1871-1881. PubMed ID: 34075638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TEAD4-YAP interaction regulates tumoral growth by controlling cell-cycle arrest at the G1 phase.
    Takeuchi S; Kasamatsu A; Yamatoji M; Nakashima D; Endo-Sakamoto Y; Koide N; Takahara T; Shimizu T; Iyoda M; Ogawara K; Shiiba M; Tanzawa H; Uzawa K
    Biochem Biophys Res Commun; 2017 Apr; 486(2):385-390. PubMed ID: 28315328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TEAD4 promotes colorectal tumorigenesis via transcriptionally targeting YAP1.
    Tang JY; Yu CY; Bao YJ; Chen L; Chen J; Yang SL; Chen HY; Hong J; Fang JY
    Cell Cycle; 2018; 17(1):102-109. PubMed ID: 29157094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular dynamics simulations study of influence of Tyr422Ala mutation on transcriptional enhancer activation domain 4 (TEAD4) and transcription co-activators complexes.
    Niu RJ; Zheng QC; Zhang HX
    J Theor Biol; 2019 Jul; 472():27-35. PubMed ID: 30978352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Crystal structure of TAZ-TEAD complex reveals a distinct interaction mode from that of YAP-TEAD complex.
    Kaan HYK; Chan SW; Tan SKJ; Guo F; Lim CJ; Hong W; Song H
    Sci Rep; 2017 May; 7(1):2035. PubMed ID: 28515457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TEA Domain Transcription Factor 4 Is the Major Mediator of Yes-Associated Protein Oncogenic Activity in Mouse and Human Hepatoblastoma.
    Zhang J; Liu P; Tao J; Wang P; Zhang Y; Song X; Che L; Sumazin P; Ribback S; Kiss A; Schaff Z; Cigliano A; Dombrowski F; Cossu C; Pascale RM; Calvisi DF; Monga SP; Chen X
    Am J Pathol; 2019 May; 189(5):1077-1090. PubMed ID: 30794805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.